Treace Medical Concepts Inc
TMCI
Market Cap$428.91M
Close$
Share Statistics
| Market cap | $428.91 Million |
|---|---|
| Enterprise Value | $487.21 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.9 |
| Beta | 0.8 |
| Outstanding Shares | 62,340,603 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.63 |
|---|---|
| PEG | 61.84 |
| Price to Sales | 2.27 |
| Price to Book Ratio | 6.82 |
| Enterprise Value to Revenue | 2.4 |
| Enterprise Value to EBIT | -7.56 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.62 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Treace Medical Concepts Inc
133 employeesBased in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion ...